Is prevention of reactivation of herpes simplex 1 virus necessary in cosmetic surgery and dermatological procedures?
Aguilar, L.; Giménez, M.J.; Prieto, J.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 18(2): 118-123
2005
ISSN/ISBN: 0214-3429 PMID: 16130033 Document Number: 586497
Document emailed within 1 workday
Related Documents
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Rajcáni, J.; Sabó, A.; Mucha, V.; Kostál, M.; Compel, P. 1995: Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation Acta Virologica 39(1): 37-49
Boulinguez, S.; Rogez, S. 1997: Herpes simplex virus: mechanism of latency and reactivation phases Annales de Dermatologie et de Venereologie 124(5): 409-415
Openshaw, H.; Puga, A.; Notkins, A.L. 1979: Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation Federation Proceedings 38(13): 2660-2664
Sheridan, J.F.; Beck, M.; Smith, C.C.; Aurelian, L. 1987: Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro Journal of Immunology 138(4): 1234-1239
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Baker, D.A.; Gonik, B.; Milch, P.O.; Berkowitz, A.; Lipson, S.; Verma, U. 1989: Clinical evaluation of a new herpes simplex virus ELISA: a rapid diagnostic test for herpes simplex virus Obstetrics and Gynecology 73(3 Part 1): 322-325
Terleth, C.; van Laar, T.; Schouten, R.; van Steeg, H.; Hodemaekers, H.; Wormhoudt, T.; Cornelissen-Steijger, P.D.; Abrahams, P.J.; van der Eb, A.J. 1997: A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients Cancer Research 57(19): 4384-4392
Rudinger, R. 1993: Neues und Altes zu anogenitalen Herpes-simplex-Virus-Infektionen - New and old aspects of anogenital herpes simplex virus infections - New and old aspects of anogenital Herpes simplex virus infections University of Koln. Department of Dermatology. Dermatological Meeting 68(1): 20-23
Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Keller, M.J.; Klotman, M.E.; Herold, B.C. 2003: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus American Journal of Reproductive Immunology 49(5): 279-284
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Wang, Z.-y.; Wang, Z.-y.; Wen, H.-L.; Tao, Z.-x. 2005: ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(2): 159-161
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Herold, B.C.; Scordi-Bello, I.; Cheshenko, N.; Marcellino, D.; Dzuzelewski, M.; Francois, F.; Morin, R.; Casullo, V.Mas.; Anderson, R.A.; Chany, C.; Waller, D.P.; Zaneveld, L.J.D.; Klotman, M.E. 2002: Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry Journal of Virology 76(22): 11236-11244
Maeglin, B. 1987: Herpes simplex. Oral and peroral infection with Herpes simplex virus Schweizer Monatsschrift für Zahnmedizin 97(12): 1532-1536
Weitgasser, H. 1973: New possibilities of herpes simplex therapy in the dermatological practice Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 24(7): 298-301
Wiersbitzky, S.; Kramer, A.; Jülich, W.D.; Jährig, D. 1988: Recommendations for the prevention of nosocomial infections caused by herpes simplex virus Kinderarztliche Praxis 56(8): 409-410
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326